Anemia resident survival guide: Difference between revisions
Line 95: | Line 95: | ||
{{familytree | | | | | |!| | | | | | | | | | | |!| | | | | | | | | | | | |!| | | | |}} | {{familytree | | | | | |!| | | | | | | | | | | |!| | | | | | | | | | | | |!| | | | |}} | ||
{{familytree | | | | | F01 | | | | | | | | | | F02 | | | | | | | | | | | F03 | | | | F01=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''[[Microcytic anemia]]'''<br> | {{familytree | | | | | F01 | | | | | | | | | | F02 | | | | | | | | | | | F03 | | | | F01=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''[[Microcytic anemia]]'''<br> | ||
:❑ [[Iron deficiency]]<br> ❑ [[Anemia of chronic disease]]<br> ❑ [[Thalassemia]]<br> ❑ [[Sideroblastic anemia]]<br> ❑ [[Lead toxicity]]|F02=<div style="float: left; text-align: left; width: | :❑ [[Iron deficiency]]<br> ❑ [[Anemia of chronic disease]]<br> ❑ [[Thalassemia]]<br> ❑ [[Sideroblastic anemia]]<br> ❑ [[Lead toxicity]]|F02=<div style="float: left; text-align: left; width: 10em; padding:1em;">'''[[Macrocytic anemia]]'''<br> | ||
❑ [[Megaloblastic anemia|Megaloblastic]] [[bone marrow]]<br> | ❑ [[Megaloblastic anemia|Megaloblastic]] [[bone marrow]]<br> | ||
:❑ [[Vitamin B12 deficiency]]<br> ❑ [[Folate deficiency]]<br> ❑ [[Medications]] ([[hydroxyurea]], [[zidovudine]], [[methotrexate]], [[chemotherapy agents]])<br> | :❑ [[Vitamin B12 deficiency]]<br> ❑ [[Folate deficiency]]<br> ❑ [[Medications]] ([[hydroxyurea]], [[zidovudine]], [[methotrexate]], [[chemotherapy agents]])<br> |
Revision as of 20:40, 30 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Chetan Lokhande, M.B.B.S [2]
Overview
Anemia is defined as a decrease in oxygen-carrying capacity of the blood . It is measured in unit volume concentrations of hemoglobin (Hb), red blood cell volume (MCV), red blood cell number (RBC count).
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.[1][2]
- Aplastic anemia
- Sickle cell anemia
- Hemolytic anemia
- Paroxysmal nocturnal hemoglobinuria
- Severe thalassemia
- Fanconi anemia
- Malaria
- Myelodysplastic syndrome
- Severe Hemorrhage
- Acute leukemia
- Disseminated intravascular coagulation (DIC)
Common causes
Common causes of anemia include:[3][4][5]
For a complete list of hemolytic anemia causes, click here
- Pregnancy
- Anemia of chronic disease
- Lead poisoning
- Liver disease
- Chronic renal disease
- Splenomegaly
- Bone marrow suppression
- Alcoholism
For a complete list of anemia causes, click here
Diagnosis
Management
Management
INDICATIONS FOR TESTING Fatigue, weakness, pallor, dizziness, fainting | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check routine Labs, CBC , smear and reticulocyte count and index | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosed as anemia if Hgb in males < 13g / dl and in females if Hgb < 12g / dl[6][7][8] Check whether corrected reticulocyte index ≥ 2.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If No Check RBC indices | If Yes then | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal MCV / MCHC Normocytic Normochromic | Low MCV / MCHC Microcytic Hypochromic | High MCV Macrocytic[9][10] | Check peripheral smear | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↓ EPO production or improper response to EPO[11][12] | Maturation defect[13] | Maturation defect | Fragmented cells on peripheral smear | No fragmented cells on peripheral smear | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Bone marrow disorder Inflammation *Autoimmune disease *Chronic renal disease *Critical illness *Chronic endocrine disorders *Aplastic anemia *Pure red cell aplasia | *Iron deficiency *Chronic disease *Thalassemia (Hemoglobinopathies) *Sideroblastic anemia *Lead toxicity | *Folate, B12 deficiency (Megaloblastic Anemia) * Drug effect *Excessive alcohol use *Hypothyroidism | Suggests hemolytic process *Metabolic defect *Hemoglobinopathies (eg, sickle cell) *Autoimmune destruction *Splenic sequestration *RBC membrane defect *Intravascular hemolysis See Hemolytic Anemia | Suspect hemorrhage and acute blood loss[14] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal peripheral smear | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If yes then work up based on smear bone marrow biopsy may be necessary | If no | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORDER Iron and Iron Binding Capacity and Ferritin check B12, Folate levels | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Start Vit B12,Folate If low | Low / normal TIBC Normal / high ferritin Low / normal iron | High TIBC Low iron Low ferritin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inflammation / Chronic Disease Consider Biopsy in this case | Iron Deficiency anemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations and Formula
MCV = mean cell volume MCHC = mean cell hemoglobin concentration TIBC = total iron binding capacity
Reticulocyte correction for anemia:
Retic Count % x Hgb / Htc x Maturation time correction
Do's
- Before evaluating for anemia, ask about the following:
- Any medical condition that could be associated
- Duration of anemia
- Ethnicity and race
- Any medication use
- Occupational history
- Determine if there is anything that shows evidence of:
- Decreased red cell production
- Increased red cell destruction
- Bleeding
- Bone marrow suppression
- Nutritional deficiency
- Do a detailed physical examination and keep a high level of suspicion
References
- ↑ "Acute Anemia - StatPearls - NCBI Bookshelf".
- ↑ Chaparro CM, Suchdev PS (August 2019). "Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries". Ann. N. Y. Acad. Sci. 1450 (1): 15–31. doi:10.1111/nyas.14092. PMC 6697587 Check
|pmc=
value (help). PMID 31008520. - ↑ Chaparro CM, Suchdev PS (2019). "Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries". Ann N Y Acad Sci. 1450 (1): 15–31. doi:10.1111/nyas.14092. PMC 6697587 Check
|pmc=
value (help). PMID 31008520. - ↑ "Anemia - Clinical Methods - NCBI Bookshelf".
- ↑ Phillips J, Henderson AC (2018). "Hemolytic Anemia: Evaluation and Differential Diagnosis". Am Fam Physician. 98 (6): 354–361. PMID 30215915.
- ↑ "Nutritional anaemias. Report of a WHO scientific group". World Health Organ Tech Rep Ser. 405: 5–37. 1968. PMID 4975372.
- ↑ Rodgers, GM.; Becker, PS.; Bennett, CL.; Cella, D.; Chanan-Khan, A.; Chesney, C.; Cleeland, C.; Coccia, PF.; Djulbegovic, B. (2008). "Cancer- and chemotherapy-induced anemia". J Natl Compr Canc Netw. 6 (6): 536–64. PMID 18597709. Unknown parameter
|month=
ignored (help) - ↑ Beutler, E.; Waalen, J. (2006). "The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?". Blood. 107 (5): 1747–50. doi:10.1182/blood-2005-07-3046. PMID 16189263. Unknown parameter
|month=
ignored (help) - ↑ Davenport, J. (1996). "Macrocytic anemia". Am Fam Physician. 53 (1): 155–62. PMID 8546042. Unknown parameter
|month=
ignored (help) - ↑ Inelmen, EM.; D'Alessio, M.; Gatto, MR.; Baggio, MB.; Jimenez, G.; Bizzotto, MG.; Enzi, G. (1994). "Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study". Aging (Milano). 6 (2): 81–9. PMID 7918735. Unknown parameter
|month=
ignored (help) - ↑ Gomes, ME.; Deinum, J.; Timmers, HJ.; Lenders, JW. (2003). "Occam's razor; anaemia and orthostatic hypotension". Lancet. 362 (9392): 1282. doi:10.1016/S0140-6736(03)14572-2. PMID 14575973. Unknown parameter
|month=
ignored (help) - ↑ Perera, R.; Isola, L.; Kaufmann, H. (1995). "Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure". Clin Auton Res. 5 (4): 211–3. PMID 8520216. Unknown parameter
|month=
ignored (help) - ↑ Camaschella, C. (2013). "How I manage patients with atypical microcytic anaemia". Br J Haematol. 160 (1): 12–24. doi:10.1111/bjh.12081. PMID 23057559. Unknown parameter
|month=
ignored (help) - ↑ Salisbury, AC.; Reid, KJ.; Alexander, KP.; Masoudi, FA.; Lai, SM.; Chan, PS.; Bach, RG.; Wang, TY.; Spertus, JA. (2011). "Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction". Arch Intern Med. 171 (18): 1646–53. doi:10.1001/archinternmed.2011.361. PMID 21824940. Unknown parameter
|month=
ignored (help)